DESCOVY (REMEDYREPACK INC.)
Welcome to the PulseAid listing for the DESCOVY drug offered from REMEDYREPACK INC.. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | REMEDYREPACK INC. |
| NON-PROPRIETARY NAME: | emtricitabine and tenofovir alafenamide fumarate |
| SUBSTANCE NAME: | EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-02-20 |
| END MARKETING DATE: | 0000-00-00 |
DESCOVY HUMAN PRESCRIPTION DRUG Details:
| Item Description | DESCOVY from REMEDYREPACK INC. |
| LABELER NAME: | REMEDYREPACK INC. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200; 25(mg/1; mg/1) |
| START MARKETING DATE: | 2017-02-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70518-0230_5d6ecdbc-ecf5-fd2c-e053-2991aa0a3832 |
| PRODUCT NDC: | 70518-0230 |
| APPLICATION NUMBER: | NDA208215 |
Other EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE Pharmaceutical Manufacturers / Labelers:
